Ionis Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference Transcript
All right. Good morning. My name is Do Kim. I'm one of the biotech analysts at BMO. Happy to have with us Brett Monia, COO of Ionis.
Questions & Answers
Brett, just to start off, as we recognize the 30 years that Ionis has been around, could you reflect on what the company has achieved in that time, where you are today and what we could expect as you transition to CEO?
Sure thing, Do, and happy to -- and good morning, everybody. I'm glad to be here. Thanks for the invitation to talk a little bit about Ionis and where we're at today.
So yes, indeed, this is our 30th-year anniversary, and there's a lot of celebrating going on right now in San Diego because we're very proud of what we've accomplished over the last 30 years. I think at the high level, Do, what we've done was
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |